Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

This activity is accompanied by a 3-part webinar curriculum. Click here to view the other webinars in this curriculum.

Program Description
This podcast will summarize the roles of pharmacists in hyperlipidemia management and supporting cardiovascular health outcomes. Best practices for managing patients with hyperlipidemia, including identifying barriers to achieving recommended low-density lipoprotein cholesterol (LDL-C) levels, integrating non-statin therapies into treatment plans, addressing challenges in patient adherence, and applying strategies to improve cardiovascular outcomes, will be discussed through integration of patient case studies. Experts will outline actionable steps to ensure the provision of patient-centered care for hyperlipidemia treatment and management in their clinical settings.

Target Audience: Community pharmacists, health system pharmacists, and specialty pharmacists

Type of Activity: Application
Release date: March 31, 2025
Expiration date: March 31, 2026
Learner level: Intermediate
Time to complete activity: 0.5 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine best practices for optimizing medication adherence and treatment initiation in hypercholesterolemia management
• Explain patient education and counseling for managing hypercholesterolemia

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Joseph Saseen, PharmD, BCPS, BCACP, CLS, has the following relevant financial relationships with commercial interests to disclose:

Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following relevant financial relationship with a commercial interest to disclose:

Grant/Research Support: Novartis

Consultant: Novartis, Regeneron

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Crissy Wilson; Susan Pordon; Brianna Winters; Chloe Taccetta, and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms